K.A. Mason
Impact in
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
Papers in
- Oncology 8
- Cancer Treatment and Pharmacology 4
- Cancer-related Molecular Pathways 2
- Pancreatic and Hepatic Oncology Research 2
- Co-authors
- Nancy Hunter (6 shared papers)L. Milas (6 shared papers)Jaime L. Masferrer (2 shared papers)Kazushi Kishi (2 shared papers)Philip J. Tofilon (2 shared papers)Lara Buchmiller (1 shared paper)Tetsuo Akimoto (1 shared paper)K.K. Ang (1 shared paper)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (4 papers)JNCI Journal of the National Cancer Institute (2 papers)European Journal of Radiology (1 paper)Radiotherapy and Oncology (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
K.A. Mason
17 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 88
- Oncology 687
- Pharmacology 322
- Cancer Research 228
- Otorhinolaryngology 61
- Pulmonary and Respiratory Medicine 440
Countries citing papers authored by K.A. Mason
This map shows the geographic impact of K.A. Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.A. Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.A. Mason more than expected).
Fields of papers citing papers by K.A. Mason
This network shows the impact of papers produced by K.A. Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.A. Mason. The network helps show where K.A. Mason may publish in the future.
Co-authors
The 25 scholars most cited alongside K.A. Mason, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas. | 1999 | 277 |
| 2 | 1996 | 252 | |
| 3 | Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor. | 2000 | 232 |
| 4 | 1999 | 197 | |
| 5 | 2002 | 157 | |
| 6 | Docetaxel enhances tumor radioresponse in vivo. | 1997 | 133 |
| 7 | Effects of hyperthermia and radiation on mouse testis stem cells. | 1981 | 24 |
| 8 | 2001 | 17 | |
| 9 | 1985 | 14 | |
| 10 | 1999 | 13 | |
| 11 | 1981 | 12 | |
| 12 | 1994 | 5 | |
| 13 | 1977 | 5 | |
| 14 | 2014 | 2 | |
| 15 | 2013 | 2 | |
| 16 | 2001 | 2 | |
| 17 | 2006 | 1 | |
| 18 | 2024 | 0 |
About K.A. Mason
K.A. Mason is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Cancer Research and Surgery, having authored 18 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Effects of Radiation Exposure (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers), Cancer Genomics and Diagnostics (2 papers), Advanced Radiotherapy Techniques (2 papers), Cancer-related Molecular Pathways (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Oncology (687 citations), Pharmacology (322 citations), Cancer Research (228 citations), Otorhinolaryngology (61 citations) and Pulmonary and Respiratory Medicine (440 citations). K.A. Mason has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Nancy Hunter, L. Milas, Jaime L. Masferrer, Kazushi Kishi, Philip J. Tofilon, Lara Buchmiller, Tetsuo Akimoto, K.K. Ang, Luka Milas and Christopher Milross. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, JNCI Journal of the National Cancer Institute, European Journal of Radiology, Radiotherapy and Oncology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.